British American Tobacco's stock declined after the company revealed one of the largest reorganizations in its recent history, announcing plans that will affect about 9,000 positions worldwide. The shares were down 1.4% to trade at 4,684p following the announcement.
The restructuring programme will directly remove 5,500 roles and move another 3,500 posts to strategic outsourcing partners, among them Accenture. Collectively, these changes touch nearly 20% of the firm's global workforce. The plan specifically leaves the company's largest market - the United States - unaffected.
Management says the operational overhaul, driven by an increased reliance on artificial intelligence and outsourcing, is expected to deliver an additional £600 million of annual savings by 2028. Those projected savings are supplemental to a previously stated objective to trim £500 million in costs by 2027.
Despite the potential for enhanced long-term margins, investors responded cautiously. Market participants have focused on the human capital consequences and the execution risks that come with a programme of this scale.
Compounding the immediate technical pressure on the share price is the timing of the company's share repurchase activity. An existing buyback arrangement with Merrill Lynch - which had been supplying a steady source of demand for the stock on the London Stock Exchange - was due to lapse at the close of business today. A new buyback programme led by UBS is scheduled to commence on June 30, 2026.
The wider market environment provided little momentum to counter the negative reaction. The FTSE 100, the index most closely tied to BAT's London listing, had moved lower in the prior session, while U.S. equity indices were modestly in the red today, reflecting a mild global risk-off tone.
Companies in the tobacco and consumer staples area felt similar caution: sector peers such as Philip Morris International and Imperial Brands did not escape the subdued sentiment.
Taken together, the market's response illustrates investors weighing a transformation that could yield meaningful cost savings against the near-term disruptions and uncertainty tied to workforce reductions and the operational shift to external partners. While the cost savings case could be supportive over time, the immediate reaction highlights investor concern about the risks inherent in executing a large-scale restructure.
Summary
- British American Tobacco announced cuts affecting about 9,000 roles, with 5,500 redundancies and 3,500 roles to be outsourced.
- The company expects an extra £600 million of annual savings by 2028, on top of £500 million targeted for 2027.
- Share buyback activity switches from a Merrill Lynch programme that expired today to a UBS-led programme starting June 30, 2026.
Key points
- Workforce and operations - The plan impacts nearly 20% of BAT's global workforce and shifts significant activity to outsourcing partners, including Accenture.
- Cost savings trajectory - Management projects sizeable incremental savings that are intended to bolster the company's cost base over the medium term.
- Market and sector context - The announcement coincided with a subdued trading backdrop for the FTSE 100 and U.S. equities, and the broader tobacco sector showed similar caution.
Risks and uncertainties
- Execution risk - Carrying out a large, AI-driven operational overhaul and substantial workforce changes creates implementation and delivery risk.
- Human capital impact - The scale of headcount reductions and moves to outsource raises concerns about disruption and transitional costs.
- Technical liquidity gap - The lapse of a Merrill Lynch buyback before a UBS-led programme begins could remove a source of demand for the shares in the near term.